Zacks analysts gave AmSurg a ranking of 3, indicting the company has a "hold" rating for the short term, according to Insider Trading Report.
Here are four observations:
1. In the short term, AmSurg shares are projected to reach $85.89.
2. Analysts predict the shares may hit a target price of $95 on the higher end and $64 on the lower end.
3. AmSurg shares are up nearly 17.8 percent in the last three-month period.
4. In the last four weeks, the shares rallied 0.53 percent.
More articles on surgery centers:
SCA receives 'sell' rating — 4 quick facts
Children's Hospital of Philadelphia opens Brandywine Valley Specialty Care and ASC: 5 things to know
10 new surgery centers in September 2015